Alkem Laboratories Ltd.
| BSE: 539523 | Sector: Health care |
| NSE: ALKEM | ISIN Code: INE540L01014 |
| BSE 10:36 | 21 Oct | 2644.95 |
-17.05 (-0.64%) |
OPEN
2679.40 |
HIGH
2679.40 |
LOW
2644.95 |
| NSE 10:34 | 21 Oct | 2641.00 |
-24.70 (-0.93%) |
OPEN
2670.00 |
HIGH
2678.90 |
LOW
2641.00 |
| OPEN | 2679.40 |
| PREVIOUS CLOSE | 2662.00 |
| VOLUME | 219 |
| 52-Week high | 3089.55 |
| 52-Week low | 1945.00 |
| P/E | 21.37 |
| Mkt Cap.(Rs cr) | 31,620 |
| Buy Price | 2643.55 |
| Buy Qty | 19.00 |
| Sell Price | 2647.90 |
| Sell Qty | 11.00 |
Alkem Laboratories Ltd. (ALKEM) - Company Information
Alkem Laboratories Ltd
Headquartered in Mumbai India Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics generic drugs active pharmaceutical ingredients (APIs) and nutraceuticals which it markets in India and international markets. Wi...> More
| COMPANY INFORMATION | |||||||
| Executive Chairman : | Basudeo N Singh | ||||||
| Joint Managing Director : | Dhananjay Kumar Singh. | ||||||
| Managing Director : | SANDEEP SINGH | ||||||
| Executive Director : | Balmiki Prasad Singh | ||||||
| Executive Director : | Mritunjay Kumar Singh | ||||||
| Independent Director : | A K Purwar | ||||||
| Independent Director : | Ranjal Laxmana Shenoy | ||||||
| Independent Director : | SANGEETA KAPILJIT SINGH | ||||||
| Independent Director : | SUDHA RAVI | ||||||
| Independent Director : | Dheeraj Sharma | ||||||
| Addtnl Independent Director : | Narendra Aneja | ||||||
| AUDITOR : | B S R & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs & Formln | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Alkem House SenapatiBapat Marg, Lower Parel,Mumbai,Maharashtra-400013 | |||||||
| Ph : 91-22-39829999 | |||||||
| WEBSITE : http://www.alkemlabs.com | |||||||
| E-mail : investors@alkem.com | |||||||
Quick Links for Alkem Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
